GlassScriptPhysician profile
Ashley May
NPI 1013463223
$3,511.88
in general payments reported to CMS, 2019-2025
21 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.90 · 2022: $1,661 · 2023: $763 · 2024: $597 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,837.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $924.91 | 2022-2025 | Belbuca, Xtampza |
| Relievant Medsystems, INC. | $866.75 | 2022-2023 | Intracept |
| Nevro Corp. | $516.71 | 2022-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $162.66 | 2022-2025 | Relistor |
| Medtronic, INC. | $160.81 | 2022 | |
| Abbott Laboratories | $154.41 | 2023 | Proclaim |
| Abbvie INC. | $95.04 | 2022-2025 | |
| Protega Pharmaceutials INC | $89.68 | 2022-2023 | Roxybond |
| Spr Therapeutics, INC | $89.20 | 2022 | |
| Averitas Pharma INC. | $67.96 | 2023-2024 | Qutenza |
| Scilex Pharmaceuticals INC. | $60.89 | 2023-2025 | Ztlido |
| Lilly USA, LLC | $48.84 | 2022-2023 | Emgality |
| Saluda Medical Americas, INC. | $47.80 | 2025 | Evoke |
| Boston Scientific Corporation | $47.40 | 2022-2025 | General - Pain Management |
| Amgen INC. | $43.48 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $28.85 | 2023 | |
| Globus Medical, INC. | $26.21 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $25.57 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $23.71 | 2022 | |
| Curonix LLC | $18.10 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Gilead Sciences, INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.